![]() |
|
|
Vol. 28, Issue 3, 323-328, March 2000
Department of Pharmacology, Faculty of Medicine, University of
Montréal and Departmento de Farmacología y
Toxicología, Centro de Investigación y de Estudios
Avanzados del I.P.N., Mexico City (G.C.H.)
To investigate how the response to a bolus and an infusion of
furosemide is modulated by the rate of fluid replacement and by
hypoalbuminemia, rabbits received 5 mg/kg of furosemide as a bolus or
infused over 60 min, whereas diuresis was replaced with 13, 121, or 238 ml/h NaCl 0.9%/glucose 5% (50:50). Natriuretic and diuretic
efficiencies were greater with the infusion than with the bolus of
furosemide. Fluid replacement increased natriuretic and diuretic
efficiency of furosemide bolus but only diuretic efficiency of
furosemide infusion. Furosemide net fluid depletion reached a plateau
when fluid replacement increased beyond 121 ml/h. Repeated
plasmapheresis decreased plasma albumin by 30% (P < .05) and increased furosemide unbound fraction
(P < .05). Compared with control rabbits,
hypoalbuminemia decreased the natriuresis of the bolus (22.7 ± 1.5-16.6 ± 1.3 mmol, P < .05) but not that elicited by furosemide infusion (26.2 ± 1.8 mmol). Given as a bolus, furosemide natriuretic and diuretic response as a function of
its urinary rate of excretion exhibited an hyperbolic relationship, and
after its infusion a clockwise hysteresis, denoting tolerance. Plasma
renin activity was increased by the bolus and the infusion of
furosemide, even in the presence of 121 ml/h of fluid replacement. It
is concluded that: 1) the increase in natriuretic/diuretic efficiency
of the bolus induced by fluid replacement is greater than when
furosemide is infused, 2) furosemide net effect does not increase
proportionally to fluid replacement, and 3) the infusion of furosemide
prevents the hypoalbuminemia-induced decrease in response of
furosemide given as a bolus.
This article has been cited by other articles:
![]() |
E. A. Klausner, E. Lavy, D. Stepensky, E. Cserepes, M. Barta, M. Friedman, and A. Hoffman Furosemide Pharmacokinetics and Pharmacodynamics following Gastroretentive Dosage Form Administration to Healthy Volunteers J. Clin. Pharmacol., July 1, 2003; 43(7): 711 - 720. [Abstract] [Full Text] [PDF] |
||||